| HOME >> BIOLOGY >> TECHNOLOGY |
Accrued expenses 18,492 18,989
Accrued compensation 13,815 14,826
Customer accommodation and quantification 17,596 18,459
Deferred income tax liability - current 4,783 4,783
Deferred revenue 17,486 16,023
Total current liabilities 82,376 85,834
Deferred income taxes 15,862 15,151
Other non-current liabilities 2,055 2,143
Shareholders' equity:
Common stock - no par value; authorized 60,000
shares; 37,544 and 37,544 shares issued and
outstanding, respectively 236,504 236,412
Retained earnings 68,459 72,876
Accumulated other comprehensive income 5,252 5,356
Total shareholders' equity 310,215 314,644
Total liabilities and shareholders' equity $410,508 $417,772
MedQuist Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(In thousands)
Unaudited
Three months ended
March 31,
2008 2007
Operating activities:
Net loss $(4,417) $(1,886)
Adjustments to reconcile net loss to cash
provided by (used in) operating activities:
Depreciation and amortization 4,289 3,885
Equity in income of affiliated company (16) (260)<
'/>"/>
| SOURCE MedQuist Inc. Copyright©2008 PR Newswire. All rights reserved |